| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Staphylococcus aureus (strain N315) Staphylococcal complement inhibitor |
|---|
| Description | 32-116aa; Full Length. MW: 25.78kD. Purity >90% as determined by SDS-PAGE. Involved in countering the first line of host defense mechanisms. Efficiently inhibits opsonization, phagocytosis and killing of S. aureus by human neutrophils. Acts by binding and stabilizing human C3 convertases (C4b2a and C3bBb), leading to their inactivation. The convertases are no longer able to cleave complement C3, therefore preventing further C3b deposition on the bacterial surface and phagocytosis of the bacteriu |
|---|
| Size | 0.01 mg (E-Coli), 0.05 mg (Yeast), 0.1 mg (Yeast), 0.05 mg (E-Coli), 0.1 mg (E-Coli) |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [SCIN] |
|---|
| Gene, Accession, CAS # | scn, Accession: WP_000702262.1 |
|---|
| Catalog # | MBS1337200 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Staphylococcus aureus (strain N315) Staphylococcal complement inhibitor from MYBIOSOURCE INC. |
|---|
| Product Specific References | Whole genome sequencing of meticillin-resistant Staphylococcus aureus.Kuroda M., Ohta T., Uchiyama I., Baba T., Yuzawa H., Kobayashi I., Cui L., Oguchi A., Aoki K., Nagai Y., Lian J.-Q., Ito T., Kanamori M., Matsumaru H., Maruyama A., Murakami H., Hosoyama A., Mizutani-Ui Y. Hiramatsu K.Lancet 357:1225-1240(2001) |
|---|
| 产品资料 |
|
|